NEOSENT: Early Anti-PD-1 Therapy In High-Risk Stage II Melanoma

Gut microbiome composition predicts melanoma recurrence risk in patients on immunotherapy, large trial finds

This study analyzed stool samples from 674 patients with resected high-risk melanoma enrolled in the phase 3 CheckMate 915 clinical trial to

Personalized mRNA vaccine shows promise in preventing melanoma recurrence when combined with immunotherapy

An 80-year-old melanoma patient, Connie Franciosi, participated in a clinical trial testing an mRNA cancer vaccine (mRNA-4157/V940) combined

Real-World EV Plus Pembro Success Seen in Urothelial Cancer

AI-guided discovery identifies GPNMB as promising CAR T cell target for multiple cancers

Researchers developed an AI-driven framework for discovering CAR T cell therapy targets by integrating single-cell RNA sequencing data from

Personalized mRNA vaccine combined with Keytruda shows 49% reduction in melanoma recurrence risk

An 80-year-old melanoma patient, Connie Franciosi, participated in a clinical trial testing an mRNA cancer vaccine (mRNA-4157/V940) combined

Personalized mRNA vaccine combined with Keytruda shows 49% reduction in melanoma recurrence risk

An 80-year-old melanoma patient, Connie Franciosi, participated in a clinical trial testing an mRNA cancer vaccine (mRNA-4157/V940) combined